LINC01800

Across TCGA pan-cancer cohorts, LINC01800 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC01800’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where LINC01800 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01800 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

UCEC, BRCA, and HNSC are the cancer types where LINC01800 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01800 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	+0.249	<.001	6	view →
BRCA	All	II,III,IV	+0.039	.010	4	view →
HNSC	All	II,III,IV	+0.034	.019	4	view →
KIRP	All	All	+0.031	.018	3	view →
KICH	All	All	−0.015	.012	3	view →
CHOL	All	All	+0.050	<.001	2	view →
LUSC	Female	II,III,IV	+0.110	.007	1	view →
LUAD	All	All	+0.081	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC01800–UCEC

Open the UCEC breakdown →